The committee is recommending that Novo Nordisk update the product label for drugs containing semaglutide to include non-arteritic anterior ischemic optic neuropathy as a side effect with a frequency of "very rare." In recent weeks, Novo Nordisk has seen its stock price tumble to multiyear lows, following a July 29 announcement that the Danish drugmaker was slashing its sales and profit projections for 2025
But its ability to reduce appetite and support weight loss has made it a popular option for people struggling with obesity and stubborn fat
Individualized planning is recommended based on gastrointestinal symptoms and aspiration risk
Every insurance provider is different, and most have a wide range of benefits plans, each with their own policies
If you want a dietitian in the loop without paying for a separate coaching program, youll love Belles weekly live webinar
These strategies focus on mitigating common issues such as nausea, vomiting, and fluctuations in blood sugar levels that may lead to health complications like diabetic retinopathy